Correction: Heparanase: A potential new factor involved in the renal epithelial mesenchymal transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury (PLoS ONE (2016) 11:7 (e0160074) DOI: 10.1371/journal.pone.0160074);Heparanase: A potential new factor involved in the renal Epithelial Mesenchymal Transition (EMT) induced by Ischemia/Reperfusion (I/R) injury

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Masola, Valentina ^a   Zaza, Gianluigi ^a   Gambaro, Giovanni ^b   Onisto, Maurizio ^c   Bellin, Gloria ^a   Vischini, Gisella ^b   Khamaysi, Iyad ^d   Hassan, Ahmad ^e   Hamoud, Shadi ^f   Nativ, Omri ^g   Heyman, Samuel N ^h   Lupo, Antonio ^a   Vlodavsky, Israel ^g   Abassi, Zaid ^g,i  

^a Renal Unit   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Institute of Gastroenterology   (Israel)

^e Medicine B   (Israel)

^f Rambam Health Care Campus   (Israel)

^g TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^h HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

ⁱ Research Unit   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FIBRONECTIN; HEPARANASE; RONEPARSTAT; VIMENTIN; BETA GLUCURONIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY ARTERY STENOSIS; KIDNEY INJURY; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; ENZYMOLOGY; KIDNEY; KIDNEY PROXIMAL TUBULE; MALE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; CELL LINE; EPITHELIAL-MESENCHYMAL TRANSITION; GLUCURONIDASE; HUMANS; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, INBRED BALB C; REPERFUSION INJURY;

EID: 84982671680     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0175618     Document Type: Erratum

References (46)

1. Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med 2011; 17: 1391-401. doi: 10.1038/nm.2507 PMID: 22064429
2. Menke J, Sollinger D, Schamberger B, Heemann U, Lutz J. The effect of ischemia/reperfusion on the kidney graft. Curr Opin Organ Transplant 2014; 19: 395-400 doi: 10.1097/MOT.0000000000000090 PMID: 24905021
3. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 2009; 361: 1570-1583. doi: 10.1056/NEJMra0901217 PMID: 19828534
4. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011; 364: 656-665. doi: 10.1056/NEJMra0910283 PMID: 21323543
5. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8: 279-289. doi: 10.1038/nri2215 PMID: 18340345
6. Ponticelli C. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. Nephrol Dial Transplant 2014; 29: 1134-1140. doi: 10.1093/ndt/gft488 PMID: 24335382
7. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333. PMID: 14668458
8. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004; 66: 480-485. PMID: 15253693
9. Yang L, Humphreys BD, Bonventre JV. Pathophysiology of acute kidney injury to chronic kidney disease: maladaptive repair. Contrib Nephrol 2011; 174: 149-155. doi: 10.1159/000329385 PMID: 21921619
10. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007; 117: 524-529. PMID: 17332879
11. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15:1-12. PMID: 14694152
12. Zell S, Schmitt R, Witting S, Kreipe HH, Hussein K, Becker JU. Hypoxia Induces Mesenchymal Gene Expression in Renal Tubular Epithelial Cells: An in vitro Model of Kidney Transplant Fibrosis. Nephron Extra 2013; 3: 50-58. doi: 10.1159/000351046 PMID: 23898346
13. Kanasaki K, Taduri G, Koya D. Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis. Front Endocrinol (Lausanne) 20013; 4:7.
14. Carew RM, Wang B, Kantharidis P. The role of EMT in renal fibrosis. Cell Tissue Res 2012; 347: 103-116. doi: 10.1007/s00441-011-1227-1 PMID: 21845400
15. Masola V, Zaza G, Onisto M, Lupo A, Gambaro G. Impact of heparanase on renal fibrosis. J Transl Med 2015; 13: 181. doi: 10.1186/s12967-015-0538-5 PMID: 26040666
16. Vlodavsky I, Ilan N, Naggi A, Casu B. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 2007; 13: 2057-2073. PMID: 17627539
17. van den Hoven MJ, Rops AL, Vlodavsky I, et al. Heparanase in glomerular diseases. Kidney Int 2007; 72: 543-538. PMID: 17519955
18. Kramer A, van den Hoven M, Rops A, Levidiotis V, Berden JH, van der Vlag J. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system. J Am Soc Nephrol 2006; 17: 2513-2520. PMID: 16899518
19. Garsen M, Rops AL, Rabelink TJ, Berden JH, van der Vlag J. The role of heparanase and the endothelial glycocalyx in the development of proteinuria. Nephrol Dial Transplant 2014; 29: 49-55. doi: 10.1093/ndt/gft410 PMID: 24166469
20. van den Hoven MJ, Rops AL, Bakker MA, Aten J, Rutjes N, Roestenberg P, et al. Increased expression of heparanase in overt diabetic nephropathy. Kidney Int 2006; 70: 2100-2118. PMID: 17051139
21. Masola V, Gambaro G, Tibaldi E, Onisto M, Abaterusso C, Lupo A. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells. Biochim Biophys Acta 2011; 1813: 1475-1482. doi: 10.1016/j.bbamcr.2011.05.004 PMID: 21600934
22. Gil N, Goldberg R, Neuman T, Garsen M, Zcharia E, Rubinstein AM, et al. Heparanase is essential for the development of diabetic nephropathy in mice. Diabetes 2012; 61: 208-216. doi: 10.2337/db11-1024 PMID: 22106160
23. Lygizos MI, Yang Y, Altmann CJ, Okamura K, Hernando AA, Perez MJ, et al. Heparanase mediates renal dysfunction during early sepsis in mice. Physiol Rep 2013; 1: e00153. doi: 10.1002/phy2.153 PMID: 24400155
24. Masola V, Gambaro G, Tibaldi E, Brunati AM, Gastaldello A, D'Angelo A, et al. Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. J Biol Chem 2012; 287: 1478-1488. doi: 10.1074/jbc.M111.279836 PMID: 22102278
25. Masola V, Zaza G, Secchi MF, Gambaro G, Lupo A, Onisto M. Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. Biochim Biophys Acta 2014; 1843: 2122-2128. doi: 10.1016/j.bbamcr.2014.06.005 PMID: 24937189
26. Zaza G, Masola V, Granata S, Bellin G, Dalla Gassa A, Onisto M, et al. Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. J Nephrol 2015; 28: 431-440. doi: 10.1007/s40620-015-0216-y PMID: 26054821
27. Naggi A, Casu B, Perez M, Torri G, Cassinelli G, Penco S, et al. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting. J Biol Chem 2005; 280: 12103-12113. PMID: 15647251
28. Pala D, Rivara S, Mor M, Milazzo FM, Roscilli G, Pavoni E et al. Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase. Glycobiology. 2016 Jun; 26(6):640-54 doi: 10.1093/glycob/cww003 PMID: 26762172
29. Rivara S, Milazzo FM, Giannini G. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases. Future Med Chem. 2016 Apr; 8(6):647-80. doi: 10.4155/fmc-2016-0012 PMID: 27057774
30. Boyango I, Barash U, Naroditsky I, Li JP, Hammond E, Ilan N, et al. Heparanase cooperates with Ras to drive breast and skin tumorigenesis. Cancer Res 2014; 74: 4504-4514. doi: 10.1158/0008-5472.CAN-13-2962 PMID: 24970482
31. Conde E, Alegre L, Blanco-Sánchez I, Sáenz-Morales D, Aguado-Fraile E, Ponte B et al. Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival.PLoS One. 2012; 7(3):e33258. doi: 10.1371/journal.pone.0033258 PMID: 22432008
32. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213-217. PMID: 16408108
33. Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest 2014; 124: 2299-2306. doi: 10.1172/JCI72267 PMID: 24892703
34. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013; 19: 1047-1053. doi: 10.1038/nm.3218 PMID: 23817022
35. Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 2003; 12:25-29. PMID: 12496662
36. Manotham K, Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 2004; 65: 871-880. PMID: 14871406
37. Zaza G, Ferraro PM, Tessari G, Sandrini S, Scolari MP, Capelli I, et al. Predictive model for delayed graft function based on easily available pre-renal transplant variables. Intern Emerg Med 205; 10: 135-141.
38. Shoskes DA, Halloran PF. Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol 1996; 155: 1831-1840. PMID: 8618268
39. Kosieradzki M, Rowiński W. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc 2008; 40: 3279-3288. doi: 10.1016/j.transproceed.2008.10.004 PMID: 19100373
40. Nangaku M, Inagi R, Miyata T, Fujita T. Hypoxia and hypoxia-inducible factor in renal disease. Nephron Exp Nephrol 2008; 110: e1-7. doi: 10.1159/000148256 PMID: 18667839
41. Z CZ, Luo C, Yang Z, Wang L. Heparanase participates in the growth and invasion of human U-2OS osteosarcoma cells and its close relationship with hypoxia-inducible factor-1α in osteosarcoma. Neoplasma 2010; 57: 562-571. PMID: 20845995
42. Du R, Xia L, Ning X, Liu L, Sun W, Huang C et al. Hypoxia-induced Bmi1 promotes renal tubular epithelial cell-mesenchymal transition and renal fibrosis via PI3K/Akt signal.MolBiol Cell. 2014 Sep 1; 25(17):2650-9.
43. Purushothaman A, Hurst DR, Pisano C, Mizumoto S, Sugahara K, Sanderson RD. Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype. J Biol Chem 2011; 286: 30377-30383. doi: 10.1074/jbc.M111.254789 PMID: 21757697
44. Lazo-Langner A, Goss GD, Spaans JN, Rodger MA. The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials. J Thromb Haemost 2007; 5: 729-737. PMID: 17408406
45. Li L, Okusa MD. Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. Semin Nephrol. 2010 May; 30(3):268-77. doi: 10.1016/j.semnephrol.2010.03.005 PMID: 20620671
46. Hertig A, Verine J, Mougenot B, Jouanneau C, Ouali N, Sebe P, et al. Risk factors for early epithelial to mesenchymal transition in renal grafts. Am J Transplant 2006; 6: 2937-2946. PMID: 17061992